DT&CRO CO., Ltd. (KOSDAQ:383930)
South Korea · Delayed Price · Currency is KRW 1,538.00
-39.00 (-2.47%)
At close: Sep 3, 2026
DT&CRO CO. Market Cap
DT&CRO CO. has a market cap or net worth of 19.47 billion as of September 4, 2026. Its market cap has decreased by -49.90% in one year.
Market Cap
19.47B
Enterprise Value
59.27B
Revenue
49.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,538.00
ChartMarket Cap Chart
Since November 11, 2022, DT&CRO CO.'s market cap has decreased from 87.47B to 19.47B, a decrease of -77.74%. That is a compound annual growth rate of -32.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 19.66B | -40.62% |
| Dec 30, 2025 | 33.11B | -55.30% |
| Dec 30, 2024 | 74.07B | -67.91% |
| Dec 28, 2023 | 230.80B | 305.63% |
| Dec 29, 2022 | 56.90B | -34.95% |
| Nov 11, 2022 | 87.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 279.29B |
| DreamCIS | 81.18B |
| P&K Skin Research Center | 52.59B |
| HLB bioStep | 41.66B |
| Kolmar BioTech | 35.34B |
| SLS BIO | 26.89B |
| C&R Research | 22.74B |
| Curachem | 12.65B |